These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 2651752)

  • 1. Chronic thromboxane inhibition preserves function of rejecting rat renal allografts.
    Coffman TM; Ruiz P; Sanfilippo F; Klotman PE
    Kidney Int; 1989 Jan; 35(1):24-30. PubMed ID: 2651752
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of chronic thromboxane inhibition with reduced in situ cytotoxic T cell activity in rejecting rat renal allografts.
    Ruiz P; Coffman TM; Klotman PE; Sanfilippo F
    Transplantation; 1989 Oct; 48(4):660-6. PubMed ID: 2799920
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of OKY-046, a selective thromboxane synthetase inhibitor, on blood pressure and thromboxane synthesis in spontaneously hypertensive rats.
    Gomi T; Ikeda T; Ishimitsu T; Uehara Y
    Prostaglandins Leukot Essent Fatty Acids; 1989 Sep; 37(3):139-44. PubMed ID: 2608692
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glomerular prostaglandin and thromboxane synthesis in rat nephrotoxic serum nephritis. Effects on renal hemodynamics.
    Lianos EA; Andres GA; Dunn MJ
    J Clin Invest; 1983 Oct; 72(4):1439-48. PubMed ID: 6685136
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional role of thromboxane production by acutely rejecting renal allografts in rats.
    Coffman TM; Yarger WE; Klotman PE
    J Clin Invest; 1985 Apr; 75(4):1242-8. PubMed ID: 3886703
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of the thromboxane synthesis inhibitor CGS-12970 on experimental acute renal allograft rejection.
    Mangino MJ; Brunt EM; Von Doersten P; Anderson CB
    J Pharmacol Exp Ther; 1989 Jan; 248(1):23-8. PubMed ID: 2643702
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Beneficial effect of a selective TXA2 synthetase inhibitor, OKY-046, both on thromboxane B2 production and vascular damage after spinal cord injury in rat spinal cord].
    Morimoto K; Ikata T; Tounai T
    Nihon Seikeigeka Gakkai Zasshi; 1990 Jan; 64(1):82-8. PubMed ID: 2319197
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The effects of thromboxane A2 synthetase inhibitor on chronic rejection of kidney transplantation].
    Imanishi M; Ikegami M; Nishioka T; Ishii T; Uemura T; Kunikata S; Kanda H; Matsuura T; Akiyama T; Kurita T
    Nihon Hinyokika Gakkai Zasshi; 1990 Jun; 81(6):895-901. PubMed ID: 2402113
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The combined use of prostaglandin I2 analogue (OP-2507) and thromboxane A2 synthetase inhibitor (OKY-046) strongly inhibits atherosclerosis of aortic allografts in rats.
    Hirano T; Nakafusa Y; Kawano R; Motoyama K; Arima T; Sugitani A; Tanaka M
    Surgery; 2001 May; 129(5):595-605. PubMed ID: 11331452
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of acute thromboxane A2 inhibition on the renal hemodynamics in a spontaneously non-insulin-dependent diabetic rat, Otsuka Long-Evans Tokushima Fatty rat.
    Uriu K; Kaizu K; Qie YL; Kai K; Eto S
    J Diabetes Complications; 1999; 13(4):182-6. PubMed ID: 10616856
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renal effects of the inhibitor of thromboxane A2-synthetase OKY-046.
    Hatziantoniou C; Papanikolaou N
    Experientia; 1986 Jun; 42(6):613-5. PubMed ID: 3522267
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the thromboxane A2 synthetase inhibitor OKY-046 in a warm ischemia-reperfusion rat model.
    Garvin PJ; Niehoff ML; Robinson SM; Heisler T; Salinas-Madrigal L; Contis J; Solomon H
    Transplantation; 1996 May; 61(10):1429-34. PubMed ID: 8633364
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravenous infusion of a selective inhibitor of thromboxane A2 synthetase in man: influence on thromboxane B2 and 6-keto-prostaglandin F1 alpha levels and platelet aggregation.
    Yui Y; Hattori R; Takatsu Y; Nakajima H; Wakabayashi A; Kawai C; Kayama N; Hiraku S; Inagawa T; Tsubojima M
    Circulation; 1984 Oct; 70(4):599-605. PubMed ID: 6434196
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence that pretransplant donor blood transfusion prevents rat renal allograft dysfunction but not the in situ cellular alloimmune or morphologic manifestations of rejection.
    Ruiz P; Coffman TM; Howell DN; Straznickas J; Scroggs MW; Baldwin WM; Klotman PE; Sanfilippo F
    Transplantation; 1988 Jan; 45(1):1-7. PubMed ID: 3276038
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of dietary fish oil supplementation on eicosanoid production by rat renal allografts.
    Coffman TM; Yohay D; Carr DR; Brazy PC; Yarger WE; Klotman PE
    Transplantation; 1988 Feb; 45(2):470-4. PubMed ID: 3125638
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new approach to antithrombotic therapy--evaluation of combined therapy of thromboxane synthetase inhibitor and very low dose of aspirin.
    Nagatsuka K; Uyama O; Nakabayashi S; Yoneda S; Kimura K; Kamada T
    Stroke; 1985; 16(5):806-9. PubMed ID: 3931302
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of OKY 046, a thromboxane-synthase inhibitor, on renal function in nonazotemic cirrhotic patients with ascites.
    Gentilini P; Laffi G; Meacci E; La Villa G; Cominelli F; Pinzani M; Buzzelli G
    Gastroenterology; 1988 Jun; 94(6):1470-7. PubMed ID: 3360268
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduction of chronic ciclosporin nephrotoxicity by thromboxane synthase inhibition with OKY-046.
    Kim YJ; Park YH; Moon HK
    Kidney Blood Press Res; 1997; 20(1):38-43. PubMed ID: 9192909
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Anti-allergic effects of (E)-3-[p-(1H-imidazol-1-ylmethyl)phenyl]-2-propenoic acid (OKY-046), a specific thromboxane (TX) A2 synthetase inhibitor: effect of OKY-046 on II-IV type allergic reactions].
    Kikuchi S; Takehana Y; Hamano S; Ichikawa K; Komatsu H; Okegawa T; Ikeda S
    Nihon Yakurigaku Zasshi; 1990 Mar; 95(3):131-7. PubMed ID: 2141317
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevention of endotoxin-induced pulmonary hypertension in primates by the use of a selective thromboxane synthetase inhibitor, OKY 1581.
    Casey LC; Fletcher JR; Zmudka MI; Ramwell PW
    J Pharmacol Exp Ther; 1982 Aug; 222(2):441-6. PubMed ID: 6896528
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.